Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay

被引:48
作者
Zeng, XY
Kong, FR
Wang, H
Darbar, A
Gilbert, GL
机构
[1] Ctr Infect Dis & Microbiol, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia
[2] Wuhan First Hosp, Dept Dermatol, Wuhan, Hubei, Peoples R China
关键词
D O I
10.1128/AAC.50.1.204-209.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Streptococcus agalactiae (group B streptococcus [GBS]) is the leading cause of neonatal and maternal sepsis. Penicillin is recommended for intrapartum prophylaxis, but erythromycin or clindamycin is used for penicillin-allergic carriers. Antibiotic resistance (AR) has increased recently and needs to be monitored. We have developed a multiplex PCR-based reverse line blot (mPCR/RLB) hybridization assay to detect, simultaneously, seven genes encoding AR-erm(A/TR), erm(B), mef(A/E), tet(M), tet(O), aphA-3, and aad-6-and two AR-related genes, int-Tn and mreA. We tested 512 GBS isolates from Asia and Australasia and compared mPCR/RLB with antibiotic susceptibility phenotype or single-gene PCR. Phenotypic resistance to tetracycline was identified in 450 (88%) isolates, of which 442 had tet(M) (93%) and/or tet(O) (6%). Of 67 (13%) erythromycin-resistant isolates, 18 were susceptible to clindamycin, i.e., had the M phenotype, encoded by mef(A/E); 39 had constitutive (cMLS(B)) and 10 inducible clindamycin resistance, and of these, 34 contained erm(B) and 12 erm(A/TR). Of four additional isolates with mef(A/E), three contained erm(B) with cMLSB and one was erythromycin susceptible. Of 61 (12%) clindamycin-resistant isolates, 20 were susceptible to erythromycin and two had intermediate resistance. Based on sequencing, 21 of 22 isolates with mef had mef(E), and 8 of 353 with int-Tn had an atypical sequence. Several AR genes, erm(B), tet(O), aphA-3, aad-6, and mef(A/E), were significantly more common among Asian than Australasian isolates, and there were significant differences in distribution of AR genes between GBS serotypes. Our mPCR/RLB assay is simple, rapid, and suitable for surveillance of antibiotic resistance in GBS.
引用
收藏
页码:204 / 209
页数:6
相关论文
共 35 条
[1]   Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital [J].
Acikgoz, ZC ;
Almayanlar, E ;
Gamberzade, S ;
Gocer, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1410-1412
[2]  
Apgar BS, 2005, AM FAM PHYSICIAN, V71, P903
[3]   Presence of mefA and mefE genes in Streptococcus agalactiae [J].
Arpin, C ;
Daube, H ;
Tessier, F ;
Quentin, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :944-946
[4]   Comparison of DNA dot blot hybridization and Lancefield capillary precipitin methods for group B streptococcal capsular typing [J].
Borchardt, SM ;
Foxman, B ;
Chaffin, DO ;
Rubens, CE ;
Tallman, PA ;
Manning, SD ;
Baker, CJ ;
Marrs, CF .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) :146-150
[5]   A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025 [J].
Bozdogan, B ;
Berrezouga, L ;
Kuo, MS ;
Yurek, DA ;
Farley, KA ;
Stockman, BJ ;
Leclercq, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :925-929
[6]   Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae [J].
Clancy, J ;
DibHajj, F ;
Petitpas, JW ;
Yuan, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) :2719-2723
[7]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[8]   Macrolide resistance gene mreA of Streptococcus agalactiae encodes a flavokinase [J].
Clarebout, G ;
Villers, C ;
Leclercq, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2280-2286
[9]   Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae [J].
Culebras, E ;
Rodriguez-Avial, I ;
Betriu, C ;
Redondo, M ;
Picazo, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1574-1576
[10]   Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada [J].
de Azavedo, JCS ;
McGavin, M ;
Duncan, C ;
Low, DE ;
McGeer, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3504-3508